Tegretol and Hair loss - a phase IV clinical study of FDA data
Hair loss is found among people who take Tegretol, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Tegretol and have Hair loss. It is created by eHealthMe based on reports of 40,528 people who have side effects when taking Tegretol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
40,528 people reported to have side effects when taking Tegretol.
Among them, 402 people (0.99%) have Hair loss.
What is Tegretol?
Tegretol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 42,341 Tegretol users for its effectiveness, alternative drugs and more.
What is Hair loss?
Hair loss is found to be associated with 3,538 drugs and 3,196 conditions by eHealthMe.
Number of Tegretol and Hair loss reports submitted per year:
Time on Tegretol when people have Hair loss *:
Gender of people who have Hair loss when taking Tegretol*:
Age of people who have Hair loss when taking Tegretol *:
Common drugs people take besides Tegretol *:
Common side effects people have besides Hair loss *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Tegretol and have Hair loss?Check whether Hair loss is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
- Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
- Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
Alternative drugs to, pros and cons of Tegretol:
- Tegretol (42,341 reports)
Hair loss treatments and more:
- Hair loss (217,594 reports)
COVID vaccines that are related to Hair loss:
- Hair loss in Moderna COVID Vaccine
- Hair loss in Pfizer BioNTech Covid Vaccine
- Hair loss in Johnson and Johnson Covid Vaccine
How severe was Hair loss and when was it recovered:
Expand to all the drugs that have ingredients of carbamazepine:
- Hair loss and drugs with ingredients of carbamazepine (643 reports)
Common drugs associated with Hair loss:
All the drugs that are associated with Hair loss:
- Hair loss (3,538 drugs)
Common conditions associated with Hair loss:
All the conditions that are associated with Hair loss:
- Hair loss (3,196 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Tegretol) and Tegretol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.